S7 — global aging demographic, but telephony, language, and trust limit reach.
What the five commandments measure
C — Control
Do you own the customer, or does a gatekeeper stand between you and revenue?
E — Entry
How hard is this to copy once it works? A rival's existence isn't the question — the durability of their advantage is.
N — Need
Is demand proven with money rather than vibes?
T — Time
Can income detach from your hours, or did you buy yourself a job?
S — Scale
How far does it reach without linear cost?
Scored on the evidence below, against CENTS as we've adapted it plus a Buffett-style moat reading of every rival — the same referee for every idea, including the ones we generate ourselves. The verdict follows the arithmetic: we never relabel a score to make it read better, and the weakest commandment is always named. The exact rubric stays in-house so the scale can't be written for.
02 — The pace test — $1M/yr
At $15/mo (assumed category price), you need 5,556 subscribers for a $1M/yr pace.
Dosly — Already live on App Store with own-voice med reminders plus caregiver sharing.
I-CAN (Polsia) — Voice-first senior companion covering meds and appointments; broader wedge than reminders alone.
04 — Demand evidence
Evidence is thin: zero Reddit signals, near-zero organic X discussion of voice-call pill reminders as SaaS.
Only tracked MRR in corpus is Bookedin at $13k — a booking product, not comparable validation.
Incumbent scale exists (Medisafe + MyTherapy ~485k ratings) but proves free-app usage, not paid voice-call willingness.
Multiple launches (Dosly, I-CAN, XRPH, Kintalks) signal builder interest; none show traction.
05 — Risks
Family payer vs. elderly user split — the payer never experiences the product's value directly.
Carrier spam-labeling can silently kill delivery of automated outbound calls.
Seniors ignore or hang up on robocalls; adherence lift unprovable without clinical data.
Free incumbents can bolt on call reminders and erase the differentiator overnight.
06 — Kill switches — what kills this with one decision
Telephony carriers / STIR-SHAKEN spam labeling — Automated outbound calls flagged as spam; seniors never answer, product value evaporates.
App Store health-app review policy — Medication-adherence claims trigger rejection or forced disclaimers, blocking mobile distribution.
Regulators (FDA/HIPAA framing) — Treating adherence prompts as clinical guidance imposes compliance cost that kills a $15 product.
Part III — The Plan if you insist on proceeding
07 — What this scan can't tell you
Cannot tell whether families will pay recurring vs. buying a one-time pill dispenser.
No data on actual call answer rates or adherence lift among elderly users.
Corpus has no revenue-verified voice-reminder competitor, so paid demand remains unmeasured.
Scores judge the market and business model — not your ability to execute. Verified MRR = independently tracked revenue; reviews/upvotes = platform-reported. Judged 2026-09-14.
08 — The wedge & the next step
No-smartphone seniors: landline/flip-phone calls with confirm-or-escalate alerts texted to the paying adult child.
Cheapest next step: Recruit 10 caregivers from Facebook/AgingCare groups, charge $15 upfront, run calls manually via Twilio for two weeks.
Not quite it? Spin the model
Business-model variations of this idea, engineered to beat 6.0 — different vertical, audience, model, or wedge. Same harsh scale. Pro feature.
One evidence-backed gap a day, free
Close — but conditional. Every morning the engine files one mined gap, scored on the same harsh scale as this one. Free at 7am AEST, unedited.
Free forever · one email a day · unsubscribe in one click.
Monitor this idea
Weekly re-scan against the live corpus. If the market moves this ShipScore by a point, or flips the verdict, you hear about it. Free while we're small.